4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0000899243-21-027891
10% owner bought 450,000 shares at $14.88 ($6,696,000)
- 10% owner acquired 2,967,075 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sands Capital Ventures Discovery Fund III, L.P. 10% owner | 2021-07-06 | Conversion | +1,124,729 | 1,124,729 | D | ||
| Sands Capital Ventures Discovery Fund III, L.P. 10% owner | 2021-07-06 | Conversion | +1,842,346 | 2,967,075 | D | ||
| Sands Capital Ventures Discovery Fund III, L.P. 10% owner | 2021-07-06 | Purchase | +450,000 | $14.88 | $6,696,000 | 3,417,075 | D |
| Derivatives | |||||||
| Sands Capital Ventures Discovery Fund III, L.P. 10% owner | 2021-07-06 | Conversion · Series A-1 Preferred Stock | −1,124,729 | 0 | D | ||
| Sands Capital Ventures Discovery Fund III, L.P. 10% owner | 2021-07-06 | Conversion · Series B Preferred Stock | −1,842,346 | 0 | D | ||
| Open-market purchases · 450,000 sh · avg $14.88 · $6,696,000 | |||||||
Loading xslF345X03/doc4.xml…